BioVaxys’ DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems
Press Releases
BioVaxys Technology Corp.  
October 31, 2024

BioVaxys’ DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems

Study Results Position Company to Target Segments of $270B+ Multi-Billion Dollar Drug Delivery Systems Market1

avatar profile Olean Times Herald

Olean Times Herald


Local & Social